Type / Class
Equity / Common Stock, par value $0.0001 per shar
Shares outstanding
22.5M
Number of holders
10
Total 13F shares, excl. options
161K
Shares change
+161K
Total reported value, excl. options
$62.8K
Value change
+$62.8K
Number of buys
10
Price
$0.40

Significant Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q3 2024

10 filings reported holding VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar as of Q3 2024.
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 161K shares of 22.5M outstanding shares and own 0.72% of the company stock.
Largest 10 shareholders include Warberg Asset Management LLC (67K shares), ARMISTICE CAPITAL, LLC (36K shares), Virtu Financial LLC (30.4K shares), HRT FINANCIAL LP (19.9K shares), Tower Research Capital LLC (TRC) (4.81K shares), UBS Group AG (2.87K shares), HARBOUR INVESTMENTS, INC. (152 shares), Federation des caisses Desjardins du Quebec (20 shares), Aspire Private Capital, LLC (14 shares), and BANK OF AMERICA CORP /DE/ (7 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.